Evidence map›Paper›PMID 42845498›Full record

ArticlebioRxiv : the preprint server for biology2026

Incomplete cerebellar circuit restoration limits functional recovery following SMN therapy in severe spinal muscular atrophy.

Sayan Ruwald, Adela Vankova, Frieda Hanschmann, Christian Menedo, Sandra Wittig, Marie L Stephan, Vanessa Dreilich, Severine Ruetze, Amy K Smith, Leonie Sowoidnich and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sayan RuwaldCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Adela VankovaCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Frieda HanschmannCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Christian MenedoCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Sandra WittigCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Marie L StephanCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Vanessa DreilichCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Severine RuetzeRudolf Schönheimer Institute of Biochemistry, Leipzig University, Leipzig, Saxony, 04103, Germany.
Amy K SmithDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Leonie SowoidnichCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Christian GeisDepartment of Neurology, Section Translational Neuroimmunology, Jena University Hospital, Jena, Thuringia, 07747, Germany.
Stefan HallermannCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Charlotte J SumnerDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Livio PellizzoniDepartment of Neurology, Columbia University, New York, NY, 10032, USA.
Beatriz Blanco-RedondoRudolf Schönheimer Institute of Biochemistry, Leipzig University, Leipzig, Saxony, 04103, Germany.
Florian GerstnerCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.
Christian M SimonCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony, 04103, Germany.

Funding

Translating Pathomechanisms into Treatment for Spinal Muscular AtrophiesR35NS122306 · NINDS · JOHNS HOPKINS UNIVERSITY · PI Charlotte Jane Sumner · 2021 to 2026
$6.3M
RNA-Mediated Mechanisms of Motor System Dysfunction in Spinal Muscular AtrophyR01NS102451 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Livio Pellizzoni · 2017 to 2026
$3.9M
Essential role of Stasimon in motor circuit development and diseaseR01NS114218 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PELLIZZONI, LIVIO · 2020 to 2024
$2.9M
Mechanisms and Therapeutic Targeting of Motor Neuron Death in SMAR01NS116400 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PELLIZZONI, LIVIO · 2020 to 2024
$2.3M
NINDS NIH HHS R01 NS102451NINDS NIH HHS R01 NS114218NINDS NIH HHS R01 NS116400NINDS NIH HHS R35 NS122306
6 · The paper itself

Abstract

Spinal muscular atrophy (SMA) is caused by a deficiency in the survival motor neuron (SMN) protein, resulting in degeneration of spinal motor neurons (MNs). However, persistent neurological deficits despite postnatal SMN-restoring therapies suggest that recovery of sensorimotor and supraspinal circuits may be incomplete. The cerebellum has recently emerged as a supraspinal contributor to motor deficits in the severe SMNΔ7 mouse model, yet it remains unclear whether cerebellar pathology is a conserved and therapeutically reversible feature across severe SMA mouse models and clinical subtypes. Here, we identify cerebellar pathology in Taiwanese SMA mice, characterized by hypoplasia, disrupted organization and loss of Purkinje cells (PCs), altered synaptic circuitry, and impaired cerebellar cortical output. Unlike the previously described p53-dependent PC degeneration in SMNΔ7 mice, cerebellar pathology in Taiwanese SMA mice was associated with developmental disorganization and external granule layer (EGL)-restricted p53 activation. Human cerebellar tissue mirrored this distinction, with p53 activation found in PCs from SMA Type I and in the EGL from SMA Type 0 individuals, indicating that cerebellar pathology arises through distinct mechanisms across severe forms of SMA. Importantly, two SMN-restoring strategies produced divergent therapeutic outcomes. In SMNΔ7 mice, AAV9-SMN prevented PC degeneration yet incompletely restored cerebellar circuitry. AAV9-SMN-treated Taiwanese mice developed severe ataxia-like deficits, retained profound cerebellar pathology, and survived to approximately one month of age. In contrast, systemic risdiplam rescued cerebellar pathology, motor behavior, and survival in both models. Together, these findings identify cerebellar pathology as a conserved yet distinct feature across severe forms of SMA and reveal cell type-specific tropism as a critical determinant of therapeutic outcome. More broadly, these findings suggest that successful recovery requires restoration of distributed supraspinal circuit integrity in addition to rescue of spinal motor pathways.

Indexed as

gene therapyMotor neuron diseaseneurodevelopmentp53 signalingSMN restorationsplicing modifiersupraspinal circuit

Identifiers

PMID42845498
PMCPMC13640787

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.